Jon graduated with a BSc (Hons) from the University of Melbourne. He undertook his PhD in immunology at the St Vincent’s Institute (Melbourne) where he studied the development of islet-specific immune cells in autoimmune diabetes. He was also part of the Tom Mandel Islet Transplantation Programme, which offered access to islet transplantation for people with type 1 diabetes. He joined NCARD in November 2014, and is currently a Cancer Council Western Australia Postdoctoral Fellow. He is interested in the immunological implications of why some mesothelioma patients respond better to therapies than others. He currently supervises PhD and Honours students, and lectures in Tumour Immunology at UWA.
Dr Jonathan Chee
DR JONATHAN CHEE
POSTDOCTORAL RESEARCH SCIENTIST
- Understanding how changes in immune cells over time contribute to cancer therapy success
- Developing novel strategies to manage cancer immunotherapy side effects
- The development of novel epigenetic targeting tools to improve mesothelioma therapy outcomes
- Repurposing anti-copper drugs to improve mesothelioma immunotherapy
- The application of TCR sequencing to understand how an individual’s immune system contributes to therapy success
- PhD candidate Joel Kidman was awarded a research scholarship from the icare NSW Dust Diseases Board
- PhD candidate Nicola Principe was awarded a UWA Richard Walter Gibbon Medical Research Scholarship.
See Dr Jonathan Chee’s UWA Profile for a full list of publications